Find participating medical centers and current study status in each of them

    Find participating medical centers

    A Study of RO7198457 (Personalized Cancer Vaccine [PCV]) as a Single Agent and in Combination With Atezolizumab in Participants With Locally Advanced or Metastatic Tumors

    • Cancer
    • Lung Cancer
    • Non-Small Cell Lung Cancer (NSCLC)
    • Breast Cancer
    • Triple Negative Breast Cancer
    • Bladder Cancer
    • Colorectal Cancer (CRC)
    • Skin Cancer
    • Malignant Melanoma
    • Renal Cell Cancer (RCC)
    • Non Small Cell Lung Carcinoma
    • Melanoma
    • Head and Neck Cancer

    For the latest version of this information please go to www.forpatients.roche.com